Syndax Pharmaceuticals (SNDX) Q1 2025 Earnings

3MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.1
-1
-0.9
-0.8

Details

Expected EPS
-0.838638
Actual EPS
-1.1
Surprise EPS
-0.26
Surprise Percent
+31.17%

Description

Syndax Pharmaceuticals (SNDX) has reported earnings of -1.1 per share for Q1 2025.

0 Comments

Share your thoughts